Xeris Biopharma Holdings

XERS

NASDAQHealth Care

Income Statement

Total Revenue$203.07M

Gross Profit$166.24M

Operating Income$-33.65M

EBITDA$-13.99M

EBIT$-26.62M

Pre-tax Income$554K

Net Income$-54.84M

Cash Equivalent$62.79M

Total Debt$270.23M

Book Value$-21.6M

Book Value Per Share-0.15

Return on Equity (ROE)-209.51%

Return on Assets (ROA)-16.97%

Return on Invested Capital (ROI)-40.77%

Net Profit Margin-27.00%

Current Ratio1.67

Quick Ratio1.12

Long-Term Debt / Equity4.14